1. Home
  2. BCYC vs LEGH Comparison

BCYC vs LEGH Comparison

Compare BCYC & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • LEGH
  • Stock Information
  • Founded
  • BCYC 2009
  • LEGH 2005
  • Country
  • BCYC United Kingdom
  • LEGH United States
  • Employees
  • BCYC N/A
  • LEGH N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • LEGH Homebuilding
  • Sector
  • BCYC Health Care
  • LEGH Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • LEGH Nasdaq
  • Market Cap
  • BCYC 565.5M
  • LEGH 646.4M
  • IPO Year
  • BCYC 2019
  • LEGH 2018
  • Fundamental
  • Price
  • BCYC $8.76
  • LEGH $22.09
  • Analyst Decision
  • BCYC Buy
  • LEGH Strong Buy
  • Analyst Count
  • BCYC 11
  • LEGH 1
  • Target Price
  • BCYC $22.91
  • LEGH $29.00
  • AVG Volume (30 Days)
  • BCYC 284.7K
  • LEGH 107.7K
  • Earning Date
  • BCYC 10-31-2025
  • LEGH 11-10-2025
  • Dividend Yield
  • BCYC N/A
  • LEGH N/A
  • EPS Growth
  • BCYC N/A
  • LEGH 2.38
  • EPS
  • BCYC N/A
  • LEGH 2.23
  • Revenue
  • BCYC $19,281,000.00
  • LEGH $184,284,000.00
  • Revenue This Year
  • BCYC N/A
  • LEGH $1.51
  • Revenue Next Year
  • BCYC N/A
  • LEGH $7.92
  • P/E Ratio
  • BCYC N/A
  • LEGH $9.95
  • Revenue Growth
  • BCYC N/A
  • LEGH 8.79
  • 52 Week Low
  • BCYC $6.10
  • LEGH $20.85
  • 52 Week High
  • BCYC $25.39
  • LEGH $29.45
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 56.40
  • LEGH 37.12
  • Support Level
  • BCYC $7.65
  • LEGH $22.10
  • Resistance Level
  • BCYC $8.75
  • LEGH $24.56
  • Average True Range (ATR)
  • BCYC 0.45
  • LEGH 0.65
  • MACD
  • BCYC -0.03
  • LEGH 0.02
  • Stochastic Oscillator
  • BCYC 55.56
  • LEGH 38.56

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.

Share on Social Networks: